Dr. Siong-Seng Liau, Consultant Hepatobiliary and Pancreatic Surgeon, Addenbrooke’s Hospital, Clinician Scientist, Honorary Senior Research Fellow, MRC Cancer Unit
Mr Liau is a Consultant Hepatopancreatobiliary Surgeon with a clinical interest in Advanced Minimally-invasive Hepatobiliary and Pancreatic Surgery. Concurrently, he was an MRC-Academy of Medical Sciences Clinician Scientist at the MRC Cancer Unit and University Department of Surgery, Addenbrooke's Hospital, Cambridge. He was fellowship-trained in HPB Surgical Oncology and Abdominal Multiorgan Transplantation at the Toronto General Hospital, Canada and in Advanced Laparoscopic HPB Surgery at L' Institut Mutualiste Montsouris, Paris, France. He obtained a Doctorate of Medicine (MD) degree with Distinction from the University of Edinburgh and received surgical training in Cambridge, Hong Kong, Paris and Edinburgh. He was also previously the International Hepatopancreatobiliary Association (IHPBA) Kenneth Warren Fellow at the Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, USA and the Cambridge University Parke-Davis Exchange Fellow with the University of Toronto, Canada.
His research interests are focussed on the biology and therapy of pancreatic cancer and neoadjuvant clinical trials of novel therapeutics for pancreatic cancer. He also has a keen research interest in clinical and oncological outcome following HPB resections. His laboratory investigations study the roles of DNA repair genes in the genetic evolution of pancreatic cancer. The long-term goal is to use the research findings for personalized pancreatic cancer therapy.